NEW YORK, Nov 2 - Gunnar Weikert may not have name recognition in the scientific community, but he has been behind some of the biggest deals the genomics sector has ever seen

As senior vice president and global head of physiomics at Bayer, he was a key player in the

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.